您的位置: 首页 > 农业专利 > 详情页

Dual OX40 agonist/IL-2 cancer therapy methods
专利权人:
Providence Health & Services - Oregon d/b/a Providence Portland Medical Center
发明人:
Redmond, William,Weinberg, Andy
申请号:
AU2012371610
公开号:
AU2012371610A1
申请日:
2012.03.02
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
OX40 is a potent immune stimulating target. Provided herein is a method of treating cancer, which includes administering to a subject in need of treatment an OX40 agonist and a common gamma chain (yc) cytokine or an active fragment, variant, analog, or derivative thereof In certain aspects the common gamma chain (yc) cytokine is interleukin-2 (IL-2) or an active fragment, variant, analog, or derivative thereof. Combined treatment with an agonist anti-OX40 mAb and IL-2 synergized to augment tumor immunotherapy against multiple tumor types. Dual therapy was also able to restore the function of anergic tumor-reactive CD8
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充